title: 3rd International Ovarian Cancer Consensus Conference: outstanding issues for future consideration.
authors.affiliation: NCIC-CTG, Canada.
authors.forename: G
authors.initials: G
authors.lastname: Stuart
authors.forename: E
authors.initials: E
authors.lastname: Avall-Lundqvist
authors.forename: A
authors.initials: A
authors.lastname: du Bois
authors.forename: M
authors.initials: M
authors.lastname: Bookman
authors.forename: D
authors.initials: D
authors.lastname: Bowtell
authors.forename: M
authors.initials: M
authors.lastname: Brady
authors.forename: A
authors.initials: A
authors.lastname: Casado
authors.forename: A
authors.initials: A
authors.lastname: Cervantes
authors.forename: E
authors.initials: E
authors.lastname: Eisenhauer
authors.forename: M
authors.initials: M
authors.lastname: Friedlaender
authors.forename: K
authors.initials: K
authors.lastname: Fujiwara
authors.forename: S
authors.initials: S
authors.lastname: Grenman
authors.forename: J P
authors.initials: JP
authors.lastname: Guastalla
authors.forename: P
authors.initials: P
authors.lastname: Harper
authors.forename: T
authors.initials: T
authors.lastname: Hogberg
authors.forename: S
authors.initials: S
authors.lastname: Kaye
authors.forename: H
authors.initials: H
authors.lastname: Kitchener
authors.forename: G
authors.initials: G
authors.lastname: Kristensen
authors.forename: R
authors.initials: R
authors.lastname: Mannel
authors.forename: W
authors.initials: W
authors.lastname: Meier
authors.forename: B
authors.initials: B
authors.lastname: Miller
authors.forename: A
authors.initials: A
authors.lastname: Oza
authors.forename: R
authors.initials: R
authors.lastname: Ozols
authors.forename: M
authors.initials: M
authors.lastname: Parmar
authors.forename: J
authors.initials: J
authors.lastname: Pfisterer
authors.forename: A
authors.initials: A
authors.lastname: Poveda
authors.forename: D
authors.initials: D
authors.lastname: Provencher
authors.forename: E
authors.initials: E
authors.lastname: Pujade-Lauraine
authors.forename: M
authors.initials: M
authors.lastname: Quinn
authors.forename: M
authors.initials: M
authors.lastname: Randall
authors.forename: J
authors.initials: J
authors.lastname: Rochon
authors.forename: G
authors.initials: G
authors.lastname: Rustin
authors.forename: S
authors.initials: S
authors.lastname: Sagae
authors.forename: F
authors.initials: F
authors.lastname: Stehman
authors.forename: E
authors.initials: E
authors.lastname: Trimble
authors.forename: T
authors.initials: T
authors.lastname: Thigpen
authors.forename: P
authors.initials: P
authors.lastname: Vasey
authors.forename: I
authors.initials: I
authors.lastname: Vergote
authors.forename: R
authors.initials: R
authors.lastname: Verheijen
authors.forename: J
authors.initials: J
authors.lastname: Vermorken
authors.forename: U
authors.initials: U
authors.lastname: Wagner
mesh_terms: D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D005260:Female; D005544:Forecasting; D006801:Humans; D010051:Ovarian Neoplasms / Q000175:diagnosis / Q000517:prevention & control / Q000628:therapy*